No Data
No Data
Investigation Into MacroGenics (MGNX) Announced by Hagens Berman
One MacroGenics Insider Raised Stake By 83% In Previous Year
Insiders were net buyers of MacroGenics, Inc.'s (NASDAQ:MGNX ) stock during the past year. That is, insiders bought more stock than they sold. Although we don't think shareholders should simply
MacroGenics (MGNX) Investigating Three of Five Patient Deaths in TAMARACK Study of Vobra Duo, Stock Flat After May 10, 2024 Crash Hagens Berman
MacroGenics (NASDAQ:MGNX Shareholders Incur Further Losses as Stock Declines 16% This Week, Taking Three-year Losses to 82%
Every investor on earth makes bad calls sometimes. But you have a problem if you face massive losses more than once in a while. So take a moment to sympathize with the long term shareholders of Macr
MacroGenics to Participate in Upcoming Investor Conference
MacroGenics to Participate in Upcoming Investor Conference ROCKVILLE, MD, June 11, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing,
Shareholders in MacroGenics (NASDAQ:MGNX) Are in the Red If They Invested Three Years Ago
HotShot369 : dam
TrytosaveabitOP HotShot369: Right! For any that took a bad hit. If it’s proven that the company hid/misled investors? I really hope this can point them in the direction of maybe getting made whole again.